Articles related to FDA

The recall of Snapchill coffee products due to potential botulinum toxin contamination highlights the importance of recognizing botulism symptoms and ensuring food safety compliance to prevent serious health risks.

The FDA has approved a combination therapy of pembrolizumab, carboplatin, and paclitaxel for advanced endometrial cancer, significantly enhancing progression-free survival rates for patients with both mismatch repair deficient and proficient statuses.

The FDA has withdrawn approval for infigratinib in advanced cholangiocarcinoma following Helsinn Healthcare SA’s request, citing recruitment difficulties for a confirmatory trial.

The FDA-approved Rejoyn app, designed for major depressive disorder, combines therapeutic exercises and emotional regulation training to complement antidepressant therapy, showing significant improvement in clinical trials.

Brazzein, now FDA-approved, emerges as a zero-calorie sweetener potentially safe for diabetic and obese populations, requiring further study to validate its health impacts.

Explore the FDA-cleared Modius Stress, offering groundbreaking ease in managing generalized anxiety with daily 30-minute sessions, showing significant reductions in GAD-7 scores in international clinical trials.